{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:13:21Z","timestamp":1707524001313},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,24]]},"DOI":"10.7759\/cureus.44047","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T16:38:27Z","timestamp":1692895107000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Non-Small-Cell Lung Carcinoma Complicated by Massive Pericardial Effusion and Cardiac Tamponade: A Case Report"],"prefix":"10.7759","author":[{"given":"Akbar","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Opal","family":"Prevatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Piercy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazneen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Marlowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Damaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel RL","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016, 66:7-30. 10.3322\/caac.21332","journal-title":"CA Cancer J Clin"},{"key":"ref2","article-title":"Pericardial disease","author":"Kasper DL","year":"2016","unstructured":"Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson J, Loscalzo J. Pericardial disease. McGraw Hill, New York, United States; 2016."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-018-1040-5","article-title":"Pericardial disease associated with malignancy","volume":"20","author":"Schusler R","year":"2018","unstructured":"Schusler R, Meyerson SL. Pericardial disease associated with malignancy. Curr Cardiol Rep. 2018, 20:92. 10.1007\/s11886-018-1040-5","journal-title":"Curr Cardiol Rep"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1007\/s11936-018-0654-7","article-title":"Pericardial disease in cancer patients","volume":"20","author":"Ghosh AK","year":"2018","unstructured":"Ghosh AK, Crake T, Manisty C, Westwood M. Pericardial disease in cancer patients. Curr Treat Options Cardiovasc Med. 2018, 20:60.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref5","article-title":"Cardiac tamponade: a clinical challenge","volume":"15","author":"Jensen JK","year":"2017","unstructured":"Jensen JK, Poulsen SH, M\u00f8lgaard H. Cardiac tamponade: a clinical challenge. ESC. 2017, 15:","journal-title":"ESC"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01386-y","article-title":"Incidence of pericardial effusion in patients with advanced non-small cell lung cancer receiving immunotherapy","volume":"37","author":"Canale ML","year":"2020","unstructured":"Canale ML, Camerini A, Casolo G, et al.. Incidence of pericardial effusion in patients with advanced non-small cell lung cancer receiving immunotherapy. Adv Ther. 2020, 37:3178-84. 10.1007\/s12325-020-01386-y","journal-title":"Adv Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.01.013","article-title":"Targeted cancer therapies with pericardial effusions requiring pericardiocentesis focusing on immune checkpoint inhibitors","volume":"123","author":"Palaskas N","year":"2019","unstructured":"Palaskas N, Morgan J, Daigle T, et al.. Targeted cancer therapies with pericardial effusions requiring pericardiocentesis focusing on immune checkpoint inhibitors. Am J Cardiol. 2019, 123:1351-7. 10.1016\/j.amjcard.2019.01.013","journal-title":"Am J Cardiol"},{"key":"ref8","article-title":"The incidence of secondary tumors of the heart and pericardium: a 10-year study","volume":"18","author":"Mukai K","year":"1988","unstructured":"Mukai K, Shinkai T, Tominaga K, Shimosato Y. The incidence of secondary tumors of the heart and pericardium: a 10-year study. Jpn J Clin Oncol. 1988, 18:195-201.","journal-title":"Jpn J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.15.234","article-title":"The spread of lung cancer to the heart, pericardium and great vessels","volume":"15","author":"Onuigbo WI","year":"1974","unstructured":"Onuigbo WI. The spread of lung cancer to the heart, pericardium and great vessels. Jpn Heart J. 1974, 15:234-8. 10.1536\/ihj.15.234","journal-title":"Jpn Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21790","article-title":"Diagnostic yield of cytopathology in evaluating pericardial effusions: clinicopathologic analysis of 419 specimens","volume":"125","author":"Saab J","year":"2017","unstructured":"Saab J, Hoda RS, Narula N, et al.. Diagnostic yield of cytopathology in evaluating pericardial effusions: clinicopathologic analysis of 419 specimens. Cancer Cytopathol. 2017, 125:128-37. 10.1002\/cncy.21790","journal-title":"Cancer Cytopathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000247","article-title":"Cardiotoxicity of immune checkpoint inhibitors","volume":"2","author":"Varricchi G","year":"2017","unstructured":"Varricchi G, Galdiero MR, Marone G, et al.. Cardiotoxicity of immune checkpoint inhibitors. ESMO Open. 2017, 2:e000247. 10.1136\/esmoopen-2017-000247","journal-title":"ESMO Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson DB","year":"2016","unstructured":"Johnson DB, Balko JM, Compton ML, et al.. Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med. 2016, 375:1749-55. 10.1056\/NEJMoa1609214","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.02.026","article-title":"Immune checkpoint inhibitor-associated pericarditis","volume":"14","author":"Altan M","year":"2019","unstructured":"Altan M, Toki MI, Gettinger SN, et al.. Immune checkpoint inhibitor-associated pericarditis. J Thorac Oncol. 2019, 14:1102-8. 10.1016\/j.jtho.2019.02.026","journal-title":"J Thorac Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem JE","year":"2018","unstructured":"Salem JE, Manouchehri A, Moey M, et al.. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol. 2018, 19:1579-89. 10.1016\/S1470-2045(18)30608-9","journal-title":"Lancet Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.2599","article-title":"CT findings in patients with pericardial effusion: differentiation of malignant and benign disease","volume":"194","author":"Sun JS","year":"2010","unstructured":"Sun JS, Park KJ, Kang DK. CT findings in patients with pericardial effusion: differentiation of malignant and benign disease. AJR Am J Roentgenol. 2010, 194:W489-94. 10.2214\/AJR.09.2599","journal-title":"AJR Am J Roentgenol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3645-4","article-title":"The value of the new scoring system for predicting neoplastic pericarditis in the patients with large pericardial effusion","volume":"25","author":"Szturmowicz M","year":"2017","unstructured":"Szturmowicz M, Pawlak-Cie\u015blik A, Fija\u0142kowska A, et al.. The value of the new scoring system for predicting neoplastic pericarditis in the patients with large pericardial effusion. Support Care Cancer. 2017, 25:2399-403. 10.1007\/s00520-017-3645-4","journal-title":"Support Care Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler Y","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, et al.. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015, 36:2921-64. 10.1093\/eurheartj\/ehv318","journal-title":"Eur Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.00.745","article-title":"Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion","volume":"23","author":"Gornik HL","year":"2005","unstructured":"Gornik HL, Gerhard-Herman M, Beckman JA. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol. 2005, 23:5211-6. 10.1200\/JCO.2005.00.745","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198508000-00009","article-title":"A surgical approach to the treatment of pericardial effusion in cancer patients","volume":"8","author":"Gregory JR","year":"1985","unstructured":"Gregory JR, McMurtrey MJ, Mountain CF. A surgical approach to the treatment of pericardial effusion in cancer patients. Am J Clin Oncol. 1985, 8:319-23. 10.1097\/00000421-198508000-00009","journal-title":"Am J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1975.00330070098016","article-title":"Pericardial effusions in patients with malignant diseases","volume":"135","author":"Flannery EP","year":"1975","unstructured":"Flannery EP, Gregoatos G, Corder MP. Pericardial effusions in patients with malignant diseases. Arch Infern Med. 1975, 135:976. 10.1001\/archinte.1975.00330070098016","journal-title":"Arch Infern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21246","article-title":"Pericardial fluid cytology: an analysis of 128 specimens over a 6-year period","volume":"121","author":"Dragoescu EA","year":"2013","unstructured":"Dragoescu EA, Liu L. Pericardial fluid cytology: an analysis of 128 specimens over a 6-year period. Cancer Cytopathol. 2013, 121:242-51. 10.1002\/cncy.21246","journal-title":"Cancer Cytopathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/181101-a-rare-case-of-non-small-cell-lung-carcinoma-complicated-by-massive-pericardial-effusion-and-cardiac-tamponade-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:35Z","timestamp":1707508535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/181101-a-rare-case-of-non-small-cell-lung-carcinoma-complicated-by-massive-pericardial-effusion-and-cardiac-tamponade-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.44047","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}